Risk stratification in chronic heart failure.

Despite advances in medical and surgical management, the prognosis of chronic heart failure remains poor. Few patients with chronic heart failure can be considered to have a good prognosis, but different trials have indicated a 6 month mortality between 5% and 60% depending on the severity of heart failure; identifying patients at truly low risk is difficult. A host of factors have been identified that predict outcome, at least in univariate analyses. Cohn wrote an article entitled ‘Poverty Amidst a Wealth of Variables’ some years ago, describing the difficulties in choosing which prognostic variables to use for clinical purposes in heart failure. This article reviews in a systematic fashion those peer-reviewed papers that have assessed the utility of prognostic variables in heart failure. This summary of existing knowledge should determine those prognostic factors that have proved most reliable so far, indicate which of the many new potential factors are most promising for further research and suggests ways in which the interpretation and reporting of such information might be improved.

[1]  B. Marino,et al.  Histomorphometric features predict 1-year outcome of patients with idiopathic dilated cardiomyopathy considered to be at low priority for cardiac transplantation. , 1994, American heart journal.

[2]  V. Rasmussen,et al.  Predictors of sudden death and death from pump failure in congestive heart failure are different. Analysis of 24 h Holter monitoring, clinical variables, blood chemistry, exercise test and radionuclide angiography. , 1997, International Journal of Cardiology.

[3]  G D Pinna,et al.  Abnormal awake respiratory patterns are common in chronic heart failure and may prevent evaluation of autonomic tone by measures of heart rate variability. , 1997, Circulation.

[4]  S. Yusuf,et al.  Natural history and patterns of current practice in heart failure , 1993 .

[5]  J. Cohn,et al.  Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. , 1984, The New England journal of medicine.

[6]  H. Fillit,et al.  Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. , 1990, The New England journal of medicine.

[7]  B. Brembilla-Perrot,et al.  The signal-averaged electrocardiogram is of limited value in patients with bundle branch block and dilated cardiomyopathy in predicting inducible ventricular tachycardia or death. , 1997, The American journal of cardiology.

[8]  P. Ponikowski,et al.  Clinical correlates and prognostic significance of the ventilatory response to exercise in chronic heart failure. , 1997, Journal of the American College of Cardiology.

[9]  R. T. Lie,et al.  Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide. , 1996, Circulation.

[10]  J. Cohn,et al.  Influence of prerandomization (baseline) variables on mortality and on the reduction of mortality by enalapril. Veterans Affairs Cooperative Study on Vasodilator Therapy of Heart Failure (V-HeFT II). V-HeFT VA Cooperative Studies Group. , 1993, Circulation.

[11]  M. Luu,et al.  Importance of hemodynamic response to therapy in predicting survival with ejection fraction ≤ 20% secondary to ischemic or nonischemic dilated cardiomyopathy , 1990 .

[12]  Therapy Study Investigators Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure , 1993, The Lancet.

[13]  M. Kotler,et al.  Dilated cardiomyopathy with mitral regurgitation: decreased survival despite a low frequency of left ventricular thrombus. , 1991, American heart journal.

[14]  F. Pelliccia,et al.  Predictors of sudden death in idiopathic dilated cardiomyopathy. , 1989, The American journal of cardiology.

[15]  W. Grimm,et al.  QT dispersion and arrhythmic events in idiopathic dilated cardiomyopathy. , 1996, The American journal of cardiology.

[16]  W. Mckenna,et al.  Usefulness of signal-averaged electrocardiogram in idiopathic dilated cardiomyopathy for identifying patients with ventricular arrhythmias. , 1993, The American journal of cardiology.

[17]  J. Cohn,et al.  Influence of Prerandomization (Baseline) Variables on Mortalit and on the Reduction of Mortalit by Enalapril Veterans Affairs Cooperative Study on Vasodilator Therapy of Heart Failure (V‐HeFT II) , 1993 .

[18]  E. Aliot,et al.  A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group. , 1995, The New England journal of medicine.

[19]  F. Tristani,et al.  Effect of Vasodilator Therapy on Mortality in Chronic Congestive Heart Failure. Results of a Veterans Administration Cooperative Study , 1987 .

[20]  L. Stevenson,et al.  The limited reliability of physical signs for estimating hemodynamics in chronic heart failure. , 1989, JAMA.

[21]  W. Kannel,et al.  The natural history of congestive heart failure: the Framingham study. , 1971, The New England journal of medicine.

[22]  K. Swedberg,et al.  Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group. , 1990, Circulation.

[23]  W G Stevenson,et al.  Comparison of frequency of late potentials in idiopathic dilated cardiomyopathy and ischemic cardiomyopathy with advanced congestive heart failure and their usefulness in predicting sudden death. , 1990, The American journal of cardiology.

[24]  K. Dickstein,et al.  Plasma proatrial natriuretic factor is predictive of clinical status in patients with congestive heart failure. , 1995, The American journal of cardiology.

[25]  L. Tavazzi,et al.  Mitral flow velocity changes after 6 months of optimized therapy provide important hemodynamic and prognostic information in patients with chronic heart failure. , 1996, American heart journal.

[26]  S. Gottlieb,et al.  The erythrocyte sedimentation rate in congestive heart failure. , 1991, The New England journal of medicine.

[27]  W. Stevenson,et al.  Inducible ventricular arrhythmias and sudden death during vasodilator therapy of severe heart failure. , 1988, American heart journal.

[28]  N. Christensen,et al.  Prognostic value of plasma catecholamines, plasma renin activity, and plasma atrial natriuretic peptide at rest and during exercise in congestive heart failure: comparison with clinical evaluation, ejection fraction, and exercise capacity. , 1995, Journal of cardiac failure.

[29]  W. Kübler,et al.  Determinants of survival in patients with congestive cardiomyopathy: quantitative morphologic findings and left ventricular hemodynamics. , 1984, Circulation.

[30]  G. Taffet,et al.  Survival of elderly men with congestive heart failure. , 1992, Age and ageing.

[31]  E. Hammond,et al.  Predictive value of immunofluorescence and electron microscopic evaluation of endomyocardial biopsies in the diagnosis and prognosis of myocarditis and idiopathic dilated cardiomyopathy. , 1987, American heart journal.

[32]  K. J. Osterziel,et al.  Baroreflex sensitivity and cardiovascular mortality in patients with mild to moderate heart failure. , 1995, British heart journal.

[33]  A. Gavazzi,et al.  Ventricular arrhythmias in dilated cardiomyopathy as an independent prognostic hallmark. Italian Multicenter Cardiomyopathy Study (SPIC) Group. , 1992, The American journal of cardiology.

[34]  A. Hall,et al.  Effect of ramipril on morbidity and mode of death among survivors of acute myocardial infarction with clinical evidence of heart failure. A report from the AIRE Study Investigators. , 1997, European heart journal.

[35]  J. Schwartz,et al.  Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation. , 1996, Circulation.

[36]  H. S. Klopfenstein,et al.  807-1 Congestive Heart Failure with Preserved Systolic Function in a Large Community-Dwelling Elderly Cohort: The Cardiovascular Health Study , 1995 .

[37]  S. Cessie,et al.  Dispersion of ventricular repolarization and arrhythmic cardiac death in coronary artery disease. , 1994, The American journal of cardiology.

[38]  E. Passamani,et al.  A randomized trial of coronary artery bypass surgery. Survival of patients with a low ejection fraction. , 1985, The New England journal of medicine.

[39]  V. Fuster,et al.  The natural history of idiopathic dilated cardiomyopathy. , 1981, The American journal of cardiology.

[40]  R N Pierson,et al.  Hemodynamic exercise testing. A valuable tool in the selection of cardiac transplantation candidates. , 1996, Circulation.

[41]  P. Janský,et al.  Epidemiology of congestive heart failure. A review. , 1989, Cor et vasa.

[42]  DonnaMancini,et al.  Coupling of Hemodynamic Measurements With Oxygen Consumption During Exercise Does Not Improve Risk Stratification in Patients With Heart Failure , 1996 .

[43]  Guidelines for the diagnosis of heart failure , 2022 .

[44]  R. Falk,et al.  Is aspirin safe for patients with heart failure? , 1995, British heart journal.

[45]  N. Arakawa,et al.  Plasma brain natriuretic peptide concentrations predict survival after acute myocardial infarction. , 1996, Journal of the American College of Cardiology.

[46]  T. David,et al.  Coronary artery bypass grafting in patients with poor ventricular function. Cardiovascular Surgeons of the University of Toronto. , 1992, The Journal of thoracic and cardiovascular surgery.

[47]  B. Griffin,et al.  Incremental prognostic value of exercise hemodynamic variables in chronic congestive heart failure secondary to coronary artery disease or to dilated cardiomyopathy. , 1991, The American journal of cardiology.

[48]  W. Stevenson,et al.  Increased risk of progressive hemodynamic deterioration in advanced heart failure patients requiring permanent pacemakers. , 1993, American heart journal.

[49]  D. Gibson,et al.  Natural history of abnormal conduction and its relation to prognosis in patients with dilated cardiomyopathy. , 1996, International journal of cardiology.

[50]  G. Gioia,et al.  Prognostic value of rest-redistribution tomographic thallium-201 imaging in ischemic cardiomyopathy. , 1995, The American journal of cardiology.

[51]  O. Febo,et al.  Tumor necrosis factor soluble receptors in patients with various degrees of congestive heart failure. , 1995, Circulation.

[52]  E. Kinney Poor survival of patients with idiopathic cardiomyopathy considered too well for transplantation. , 1988, The American journal of medicine.

[53]  I Ford,et al.  Mortality in heart failure: clinical variables of prognostic value. , 1987, British heart journal.

[54]  J. Thomas,et al.  Prognostic value of dobutamine echocardiography in patients with left ventricular dysfunction. , 1996, Journal of the American College of Cardiology.

[55]  C R Benedict,et al.  Prognostic significance of plasma norepinephrine in patients with asymptomatic left ventricular dysfunction. SOLVD Investigators. , 1996, Circulation.

[56]  L. Mickleborough,et al.  Results of revascularization in patients with severe left ventricular dysfunction. , 1995, The Journal of thoracic and cardiovascular surgery.

[57]  S. Yusuf,et al.  Overview of Randomized Trials of Angiotensin-Converting Enzyme Inhibitors on Mortality and Morbidity in Patients With Heart Failure , 1995 .

[58]  S. Anker,et al.  Metabolic, functional, and haemodynamic staging for CHF? , 1996, The Lancet.

[59]  C. Lang,et al.  QT dispersion and sudden unexpected death in chronic heart failure , 1994, The Lancet.

[60]  L. Mickleborough,et al.  Results of revascularization in patients with severe left ventricular dysfunction. , 2000, Circulation.

[61]  L. Wilkins A randomized trial of beta-blockade in heart failure. The Cardiac Insufficiency Bisoprolol Study (CIBIS). CIBIS Investigators and Committees. , 1994, Circulation.

[62]  R. Frye Chronic congestive heart failure. Eight steps in management. , 1981, Postgraduate medicine.

[63]  D. Mancini,et al.  Peak VO2is superior to 6 minute walk for the prediction of survival in patients with heart failure , 1996 .

[64]  W. Stevenson,et al.  Significance of aborted cardiac arrest and sustained ventricular tachycardia in patients referred for treatment therapy of advanced heart failure. , 1992, American heart journal.

[65]  N. Bowles,et al.  Clinical and prognostic significance of detection of enteroviral RNA in the myocardium of patients with myocarditis or dilated cardiomyopathy. , 1994, Circulation.

[66]  D. Pinsky,et al.  QT dispersion as a marker of risk in patients awaiting heart transplantation. , 1997, Journal of the American College of Cardiology.

[67]  P. Batin,et al.  The importance of abnormalities of liver function tests in predicting mortality in chronic heart failure. , 1995, European heart journal.

[68]  J. Cohn,et al.  Incidence of Thromboembolic Events in Congestive Heart Failure , 1993, Circulation.

[69]  H. Figulla,et al.  Occurrence and clinical significance of endocardial late potentials and fractionations in idiopathic dilated cardiomyopathy. , 1988, British heart journal.

[70]  R. Soufer,et al.  Long-term outcome in patients with congestive heart failure and intact systolic left ventricular performance. , 1992, The American journal of cardiology.

[71]  W. Rand,et al.  Effect of warfarin anticoagulation on survival in patients with left ventricular systolic dysfunction , 1996 .

[72]  T. LeJemtel,et al.  Low incidence of stroke in ambulatory patients with heart failure: a prospective study. , 1993, American heart journal.

[73]  T. Suzuki,et al.  Myocardial contractile reserve as prognostic determinant in patients with idiopathic dilated cardiomyopathy without overt heart failure. , 1997, Chest.

[74]  G. Maurer,et al.  Prognostic impact of big endothelin-1 plasma concentrations compared with invasive hemodynamic evaluation in severe heart failure. , 1996, Journal of the American College of Cardiology.

[75]  D. Levy,et al.  Survival After the Onset of Congestive Heart Failure in Framingham Heart Study Subjects , 1993, Circulation.

[76]  L. Køber,et al.  An echocardiographic method for selecting high risk patients shortly after acute myocardial infarction, for inclusion in multi-centre studies (as used in the TRACE study). TRAndolapril Cardiac Evaluation. , 1994, European heart journal.

[77]  J R Wilson,et al.  Value of Peak Exercise Oxygen Consumption for Optimal Timing of Cardiac Transplantation in Ambulatory Patients With Heart Failure , 1991, Circulation.

[78]  J. Schroeder,et al.  Analysis of deaths in patients awaiting heart transplantation: impact on patient selection criteria. , 1996, Heart.

[79]  P. Ponikowski,et al.  Wasting as independent risk factor for mortality in chronic heart failure , 1997, The Lancet.

[80]  D J van Veldhuisen,et al.  Prognostic value of heart rate variability in chronic congestive heart failure secondary to idiopathic or ischemic dilated cardiomyopathy. , 1997, The American journal of cardiology.

[81]  H. Doval,et al.  Randomised trial of low-dose amiodarone in severe congestive heart failure , 1994, The Lancet.

[82]  G. Francis,et al.  Congestive Cardiac Failure: Pathophysiology and Treatment , 1993 .

[83]  S. Anker,et al.  Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. , 1997, Circulation.

[84]  G. Roul,et al.  Prognostic factors of chronic heart failure in NYHA class II or III: value of invasive exercise haemodynamic data. , 1995, European heart journal.

[85]  J. Rouleau,et al.  Long-term predictors of sudden and low output death in chronic congestive heart failure secondary to coronary artery disease. , 1989, The American journal of cardiology.

[86]  D. Levy,et al.  Predicting survival in heart failure case and control subjects by use of fully automated methods for deriving nonlinear and conventional indices of heart rate dynamics. , 1997, Circulation.

[87]  J. Cohn,et al.  Survival in men with severe chronic left ventricular failure due to either coronary heart disease or idiopathic dilated cardiomyopathy. , 1983, The American journal of cardiology.

[88]  C. Maynard,et al.  Results of coronary artery surgery in patients with poor left ventricular function (CASS). , 1983, Circulation.

[89]  W. Kübler,et al.  Long-term prognostic significance of ventricular arrhythmias in idiopathic dilated cardiomyopathy. , 1988, The American journal of cardiology.

[90]  A. DeMaria,et al.  Prognostic value of Doppler transmitral flow patterns in patients with congestive heart failure. , 1994, Journal of the American College of Cardiology.

[91]  A. Coats,et al.  Assessment of Chronic Heart Failure Using Gas Exchange: Which Variable and When to Correct for Body Mass , 1999, Cardiology.

[92]  S L Winters,et al.  Predictors of long-term survival in patients with malignant ventricular arrhythmias. , 1997, The American journal of cardiology.

[93]  H. Kay,et al.  Clinical determinants of mortality in chronic congestive heart failure secondary to idiopathic dilated or to ischemic cardiomyopathy. , 1987, The American journal of cardiology.

[94]  D R Nul,et al.  Heart rate is a marker of amiodarone mortality reduction in severe heart failure. The GESICA-GEMA Investigators. Grupo de Estudio de la Sobrevida en la Insuficiencia Cardiaca en Argentina-Grupo de Estudios Multicéntricos en Argentina. , 1997, Journal of the American College of Cardiology.

[95]  G. Murray,et al.  Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators , 1993 .

[96]  M. Packer,et al.  Prognostic importance of serum sodium concentration and its modification by converting-enzyme inhibition in patients with severe chronic heart failure. , 1986, Circulation.

[97]  M. Moeschberger,et al.  Factors influencing the one-year mortality of dilated cardiomyopathy. , 1984, The American journal of cardiology.

[98]  S. Hohnloser,et al.  Mode of death in idiopathic dilated cardiomyopathy: a multivariate analysis of prognostic determinants. , 1988, American heart journal.

[99]  G. Roul,et al.  Exercise peak VO2 determination in chronic heart failure: is it still of value? , 1994, European heart journal.

[100]  M Malik,et al.  Heart rate variability in idiopathic dilated cardiomyopathy: relation to disease severity and prognosis. , 1997, Heart.

[101]  G. Maurer,et al.  Validation of big endothelin plasma levels compared with established neurohumoral markers in patients with severe chronic heart failure. , 1997, Transplantation proceedings.

[102]  A. Camm,et al.  QT dispersion and RR variations on 12-lead ECGs in patients with congestive heart failure secondary to idiopathic dilated cardiomyopathy. , 1996, European heart journal.

[103]  K. Bailey,et al.  Long-term outcome of patients with biopsy-proved myocarditis: comparison with idiopathic dilated cardiomyopathy. , 1995, Journal of the American College of Cardiology.

[104]  W G Stevenson,et al.  Prognostic Significance of Atrial Fibrillation in Advanced Heart Failure: A Study of 390 Patients , 1991, Circulation.

[105]  B. Massie,et al.  Correlates and prognostic implication of exercise capacity in chronic congestive heart failure. , 1985, The American journal of cardiology.

[106]  W. Stevenson,et al.  Syncope in advanced heart failure: high risk of sudden death regardless of origin of syncope. , 1993, Journal of the American College of Cardiology.

[107]  B. Pitt,et al.  Predictors of total mortality and sudden death in mild to moderate heart failure. Captopril-Digoxin Study Group. , 1989, Journal of the American College of Cardiology.

[108]  A. Jacobs,et al.  Congestive heart failure in patients with coronary artery disease: the gender paradox. , 1997, American heart journal.

[109]  S. Yusuf,et al.  Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD). , 1990, Circulation.

[110]  P. Ponikowski,et al.  Depressed heart rate variability as an independent predictor of death in chronic congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. , 1997, The American journal of cardiology.

[111]  T. Forster,et al.  Familial dilated cardiomyopathy: a worse prognosis compared with sporadic forms. , 1995, British heart journal.

[112]  C Larizza,et al.  Predictors of prognosis in patients awaiting heart transplantation. , 1993, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[113]  R. Shabetai,et al.  Prediction of outcome in late-stage cardiomyopathy. , 1990, American heart journal.

[114]  S. Neubauer,et al.  Myocardial phosphocreatine-to-ATP ratio is a predictor of mortality in patients with dilated cardiomyopathy. , 1997, Circulation.

[115]  J. Cohn,et al.  The Influence of Atrial Fibrillation on Prognosis in Mild to Moderate Heart Failure The V‐HeFT Studies , 1993, Circulation.

[116]  J. Cohn Prognostic factors in heart failure: Poverty amidst a wealth of variables , 1989 .

[117]  Salim Yusuf,et al.  Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. , 1991, The New England journal of medicine.

[118]  S. Snapinn,et al.  The plasma concentration of N‐terminal proatrial natriuretic factor anf (1‐98) is related to prognosis in severe heart failure , 1994, Clinical cardiology.

[119]  G D Pinna,et al.  Arterial baroreflex modulation of heart rate in chronic heart failure: clinical and hemodynamic correlates and prognostic implications. , 1997, Circulation.

[120]  B. Lindsay,et al.  Prospective detection of vulnerability to sustained ventricular tachycardia in patients awaiting cardiac transplantation. , 1992, The American journal of cardiology.

[121]  J H Patterson,et al.  Relation between gender, etiology and survival in patients with symptomatic heart failure. , 1996, Journal of the American College of Cardiology.

[122]  W. Stevenson,et al.  Improving survival for patients with atrial fibrillation and advanced heart failure. , 1996, Journal of the American College of Cardiology.

[123]  J. Albenque,et al.  Prognostic value of late potentials in patients with congestive heart failure. , 1996, European heart journal.

[124]  E. Caref,et al.  Risk stratification for arrhythmic events in patients with nonischemic dilated cardiomyopathy and nonsustained ventricular tachycardia: role of programmed ventricular stimulation and the signal-averaged electrocardiogram. , 1994, Journal of the American College of Cardiology.

[125]  F Boomsma,et al.  Prognostic value of heart rate variability during long-term follow-up in patients with mild to moderate heart failure. The Dutch Ibopamine Multicenter Trial Study Group. , 1996, Journal of the American College of Cardiology.

[126]  M. Landsman,et al.  Comparison between New York Heart Association classification and peak oxygen consumption in the assessment of functional status and prognosis in patients with mild to moderate chronic congestive heart failure secondary to either ischemic or idiopathic dilated cardiomyopathy. , 1992, The American journal of cardiology.

[127]  J. Cleland Anticoagulant and antiplatelet therapy in heart failure. , 1997, Current opinion in cardiology.

[128]  F. Tristani,et al.  Effect of Vasodilator Therapy on Mortality in Chronic Congestive Heart Failure , 1986 .

[129]  B. Lerman,et al.  Electrophysiological Evaluation of Sustained Ventricular Tachyarrhythmias in Idiopathic Dilated Cardiomyopathy , 1988, Pacing and clinical electrophysiology : PACE.

[130]  N. Danchin,et al.  Additional predictive value of both left and right ventricular ejection fractions on long-term survival in idiopathic dilated cardiomyopathy. , 1997, European heart journal.

[131]  M. Costanzo,et al.  Role of maximal oxygen consumption in establishment of heart transplant candidacy for heart failure patients with intermediate exercise tolerance. , 1997, The American journal of cardiology.

[132]  L. Horowitz,et al.  Prognosis in severe heart failure: relation to hemodynamic measurements and ventricular ectopic activity. , 1983, Journal of the American College of Cardiology.

[133]  M. A. Plant Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality , 1991 .

[134]  J. Remes,et al.  Validity of clinical diagnosis of heart failure in primary health care. , 1991, European heart journal.

[135]  M. Josephson,et al.  Abnormal signal-averaged electrocardiograms in patients with nonischemic congestive cardiomyopathy: relationship to sustained ventricular tachyarrhythmias. , 1985, Circulation.

[136]  S. Pu,et al.  [Factors predicting mortality in idiopathic dilated cardiomyopathy]. , 1992, Zhonghua nei ke za zhi.

[137]  W. Stevenson,et al.  Predicting death from progressive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. , 1993, The American journal of cardiology.

[138]  M. Rich,et al.  Course and prognosis in patients > or = 70 years of age with congestive heart failure and normal versus abnormal left ventricular ejection fraction. , 1997, The American journal of cardiology.

[139]  C. T. Layton,et al.  Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia , 1996 .

[140]  S. Yusuf,et al.  Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials. , 1995, JAMA.

[141]  G. Fonarow,et al.  Prediction of improvement in recent onset cardiomyopathy after referral for heart transplantation. , 1994, Journal of the American College of Cardiology.

[142]  M. Gold,et al.  Prognostic importance of the length of ventricular tachycardia in patients with nonischemic congestive heart failure. , 1995, American heart journal.

[143]  M. Zimmermann,et al.  Significance of ventricular late potentials in non-ischaemic dilated cardiomyopathy. , 1992, European heart journal.

[144]  A Costard-Jäckle,et al.  Influence of preoperative pulmonary artery pressure on mortality after heart transplantation: testing of potential reversibility of pulmonary hypertension with nitroprusside is useful in defining a high risk group. , 1992, Journal of the American College of Cardiology.

[145]  T. Meinertz,et al.  Determinants of prognosis in idiopathic dilated cardiomyopathy as determined by programmed electrical stimulation. , 1985, The American journal of cardiology.

[146]  G. Fonarow,et al.  Impact of left ventricular cavity size on survival in advanced heart failure. , 1993, The American journal of cardiology.

[147]  J. Hansen,et al.  Chronic congestive heart failure. Description and survival of 190 consecutive patients with a diagnosis of chronic congestive heart failure based on clinical signs and symptoms. , 1994, European heart journal.

[148]  J. Blanc,et al.  Long-term prognosis in patients with alcoholic cardiomyopathy and severe heart failure after total abstinence. , 1997, The American journal of cardiology.

[149]  J. Kelly,et al.  Pulmonary Hypertension Predicts Mortality and Morbidity in Patients with Dilated Cardiomyopathy , 1992, Annals of Internal Medicine.

[150]  W. Klein,et al.  Syncope in dilated cardiomyopathy is a predictor of sudden cardiac death. , 1996, Cardiology.

[151]  B. W. East,et al.  Relation of arrhythmias and electrolyte abnormalities to survival in patients with severe chronic heart failure. , 1987, Circulation.

[152]  A. Giordano,et al.  Independent and incremental prognostic value of Doppler-derived mitral deceleration time of early filling in both symptomatic and asymptomatic patients with left ventricular dysfunction. , 1996, Journal of the American College of Cardiology.

[153]  P. Binkley,et al.  Plasma Endothelin Correlates With the Extent of Pulmonary Hypertension in Patients With Chronic Congestive Heart Failure , 1992, Circulation.

[154]  J Keegan,et al.  Predictors of prognosis in severe chronic heart failure. , 1992, American heart journal.

[155]  D. Fukai,et al.  Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction. , 1997, Circulation.

[156]  F. Tristani,et al.  Ejection Fraction, Peak Exercise Oxygen Consumption, Cardiothoracic Ratio, Ventricular Arrhythmias, and Plasma Norepinephrine as Determinants of Prognosis in Heart Failure , 1993, Circulation.

[157]  R. Cooper,et al.  Trends in hospitalization rates for heart failure in the United States, 1973-1986. Evidence for increasing population prevalence. , 1990, Archives of internal medicine.

[158]  S. Yusuf,et al.  Diabetes mellitus, a predictor of morbidity and mortality in the Studies of Left Ventricular Dysfunction (SOLVD) Trials and Registry. , 1996, The American journal of cardiology.

[159]  William J. Rogers,et al.  Prediction of Mortality and Morbidity With a 6-Minute Walk Test in Patients With Left Ventricular Dysfunction , 1993 .

[160]  R. Carney,et al.  A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure. , 1995, The New England journal of medicine.

[161]  M. Fisher,et al.  Prognostic importance of the serum magnesium concentration in patients with congestive heart failure. , 1990, Journal of the American College of Cardiology.

[162]  T. David,et al.  Coronary artery bypass grafting in patients with poor ventricular function , 1992 .

[163]  D. Andresen,et al.  First- or second-degree atrioventricular block as a risk factor in idiopathic dilated cardiomyopathy. , 1993, The American journal of cardiology.

[164]  S. Kaul,et al.  Quantitative Planar Rest‐Redistribution 201 Imaging in Detection of Myocardial Viability and Prediction of Improvement in Left Ventricular Function After Coronary Bypass Surgery in Patients With Severely Depressed Left Ventricular Function , 1993, Circulation.

[165]  A. Keogh,et al.  Prognostic guides in patients with idiopathic or ischemic dilated cardiomyopathy assessed for cardiac transplantation. , 1990, The American journal of cardiology.

[166]  A J Cowley,et al.  Relation of daily activity levels in patients with chronic heart failure to long-term prognosis. , 1997, The American journal of cardiology.

[167]  W. Littler,et al.  Factors influencing survival and mode of death in severe chronic ischaemic cardiac failure. , 1987, British heart journal.

[168]  B. Pitt,et al.  Effect of enalapril on myocardial infarction and unstable angina in patients with low ejection fractions , 1992, The Lancet.

[169]  M. Mathier,et al.  Preserved right ventricular ejection fraction predicts exercise capacity and survival in advanced heart failure. , 1995, Journal of the American College of Cardiology.

[170]  K. Swedberg,et al.  Beta-blocking agents in heart failure. Should they be used and how? , 1996, European heart journal.

[171]  G. MacGowan,et al.  Exercise-related ventilatory abnormalities and survival in congestive heart failure. , 1997, The American journal of cardiology.

[172]  J. Cohn,et al.  Echocardiographic Variables as Prognostic Indicators and Therapeutic Monitors in Chronic Congestive Heart Failure Veterans Affairs Cooperative Studies V‐HeFT I and II , 1993, Circulation.

[173]  L. Fauchier,et al.  Heart rate variability in idiopathic dilated cardiomyopathy: characteristics and prognostic value. , 1997, Journal of the American College of Cardiology.

[174]  J. Schroeder,et al.  Transplant candidates with severe left ventricular dysfunction managed with medical treatment: characteristics and survival. , 1996, Journal of the American College of Cardiology.

[175]  L. Tavazzi,et al.  Loading manipulations improve the prognostic value of Doppler evaluation of mitral flow in patients with chronic heart failure. , 1997, Circulation.

[176]  M. Anguita,et al.  Clinical and hemodynamic predictors of survival in patients aged < 65 years with severe congestive heart failure secondary to ischemic or nonischemic dilated cardiomyopathy. , 1993, The American journal of cardiology.

[177]  G. Yi,et al.  Prognostic significance of spectral turbulence analysis of the signal-averaged electrocardiogram in patients with idiopathic dilated cardiomyopathy. , 1995, The American journal of cardiology.

[178]  B. Pitt Clinical Trials in Cardiology , 1997 .

[179]  L. Tavazzi,et al.  Prognostic implications of autonomic nervous system analysis in chronic heart failure: role of heart rate variability and baroreflex sensitivity. , 1996, Archives of gerontology and geriatrics.

[180]  M. Pfisterer,et al.  Differences of disease progression in congestive heart failure due to alcoholic as compared to idiopathic dilated cardiomyopathy. , 1996, European heart journal.

[181]  W. J. Maclntyre,et al.  Prognosis of Patients With Left Ventricular Dysfunction, With and Without Viable Myocardium After Myocardial Infarction: Relative Efficacy of Medical Therapy and Revascularization , 1994, Circulation.

[182]  R. Simon,et al.  Repolarization dispersion and sudden cardiac death in patients with impaired left ventricular function. , 1997, European heart journal.

[183]  A. Kawamura,et al.  Anticoagulants and antiplatelet agents , 2004, Cardiovascular Drugs and Therapy.

[184]  A J Tajik,et al.  Two-Dimensional and Doppler Echocardiography Alone Can Adequately Define Preoperative Anatomy and Hemodynamic Status before Repair of Complete Atrioventricular Septal Defect in Infants <1 Year Old , 1994, Circulation.

[185]  H. Figulla,et al.  Prognostic value of Doppler echocardiographic assessment of left ventricular filling in idiopathic dilated cardiomyopathy. , 1994, The American journal of cardiology.

[186]  D. Fukai,et al.  Prognostic value of plasma soluble intercellular adhesion molecule-1 and endothelin-1 concentration in patients with chronic congestive heart failure. , 1995, The American journal of cardiology.

[187]  L. S. Mortensen,et al.  Prognostic value of echocardiography in 190 patients with chronic congestive heart failure. A comparison with New York Heart Association functional classes and radionuclide ventriculography. , 1996, Cardiology.

[188]  C M O'Connor,et al.  Clinical determinants of mortality in patients with angiographically diagnosed ischemic or nonischemic cardiomyopathy. , 1997, Journal of the American College of Cardiology.

[189]  T. Inoue,et al.  Value of the signal-averaged electrocardiogram as a predictor of sudden death in myocardial infarction and dilated cardiomyopathy. , 1990, Japanese circulation journal.

[190]  P C Deedwania,et al.  Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure. , 1995, The New England journal of medicine.

[191]  M. Gold,et al.  Prognostic value of the signal-averaged electrocardiogram and a prolonged QRS in ischemic and nonischemic cardiomyopathy. , 1995, The American journal of cardiology.

[192]  J. Cohn,et al.  Influence of Age on Mechanisms and Prognosis of Heart Failure , 1993, Circulation.

[193]  Mortality risk and patterns of practice in 4606 acute care patients with congestive heart failure. The relative importance of age, sex, and medical therapy. Clinical Quality Improvement Network Investigators. , 1996, Archives of internal medicine.

[194]  J. Cleland,et al.  Neuroendocrine activation after myocardial infarction: causes and consequences , 1996, Heart.

[195]  S. Brozena,et al.  Assessing risk by hemodynamic profile in patients awaiting cardiac transplantation. , 1994, The American journal of cardiology.

[196]  D. Mancini,et al.  Prognostic Value of an Abnormal Signal‐Averaged Electrocardiogram in Patients With Nonischemic Congestive Cardiomyopathy , 1993, Circulation.

[197]  G. Lamas,et al.  N-terminal proatrial natriuretic factor. An independent predictor of long-term prognosis after myocardial infarction. , 1994, Circulation.

[198]  M. Komajda,et al.  Prognostic value of plasma endothelin-1 in patients with chronic heart failure. , 1997, European heart journal.

[199]  S. Gottlieb,et al.  Prognostic importance of atrial natriuretic peptide in patients with chronic heart failure. , 1989, Journal of the American College of Cardiology.

[200]  A. Marmor,et al.  Prognostic value of noninvasively obtained left ventricular contractile reserve in patients with severe heart failure. , 1997, Journal of the American College of Cardiology.

[201]  M. Phelps,et al.  Value of metabolic imaging with positron emission tomography for evaluating prognosis in patients with coronary artery disease and left ventricular dysfunction. , 1994, The American journal of cardiology.

[202]  W. White,et al.  Coronary artery bypass in patients with severely depressed ventricular function. , 1993, The Annals of thoracic surgery.